Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Suspended 1Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasms 1Lung Neoplasms 1

Interventions

Cisplatin 4Docetaxel 3pembrolizumab 2Nivolumab 2Etoposide 2Carboplatin 2osimertinib 1icotinib 1famitinib 1durvalumab 1decitabine and cedazuridine drug combination 1dabrafenib 1cemiplimab 1alirocumab 1aldesleukin 1Surgical Procedures, Operative 1Specimen Handling 1Radiotherapy 1Radiosurgery 1Radionuclide Imaging 1Radiation 1Prednisone 1Positron-Emission Tomography 1Platinum 1Pemetrexed 1Panitumumab 1Paclitaxel 1Monatide (IMS 3015) 1Methods 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Radionuclide Imaging × Thoracic × Clear all
NCT04017819 2025-11-05

Biodistribution&Pharmacokinetic of Position Emission Tomography(PET) Radiopharmaceutical 18F C SNAT4

Stanford University

Phase 1 Suspended
20 enrolled
Thoracic

Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡